Diyaliz Hastalarında Semptom Yönetimi

Year 2009, Volume: 06 Issue: 1-2, 4 - 10, 31.12.2009

Feray Gökdoğan

Abstract

Son dönem böbrek hastalığı (SDBH) nın tedavisinde

diyaliz tekniği ve teknolojisinde son 40 y›lda

önemli ilerlemeler görülmesine karşın, intra/interdiyaliz

morbiditesinde fazla bir değişliklik olmamıştır. Morbidite,

hemodiyaliz süreci ile ortaya çıkan fizyolojik

değişikliklere bağlı çeşitli semptomları kapsamaktadır.

SDBH olan hastaların semptom yönetimine odaklanan

özelleşmiş bir bakımı alamamasının nedeni olarak

semptomların etkili bir şekilde kontrol edilememesi

ve hemşirelerin semptom yönetiminde, bakımın

planlanması ve uygulanmasında yetersiz kalması gösterilmektedir.

Diyaliz hastalarına bakım veren hemşirelerin

semptom yönetimi ve liderlik rollerini geliştirmede

eğitim programlarından ve örnek klinik uygulamalardan

yararlanarak kendilerini geliştirmeleri beklenmektedir.

Semptom yönetiminin amacı; semptom

yönetimi alanında bilgi geliştirmek ve sağlık bakım

elemanlarının uygulamaları ile kişilerdeki semptomları

iyileştirmektir. Bu semptomların başarılı bir şekilde

tedavi edilmesinin, diyaliz hastalarının yaşlam kalitelerinde

de önemli iyileşmeler sağlayacağı ileri sürülmektedir.

Keywords

Diyaliz, Semptom yönetimi, Hemşirelik bakımı, Anoreksiya, Kramplar.

References

• 1. McLaren P, Hunter C. Sodium profiling: The Key to reducing symptoms of dialysis. Nephrology Nursing Journal July-August 2007; 34( 4): 403-414.
• 2. Bonomini V, Coli U, Scolari, MP. Profiling dialysis: A new approach to dialysis intolerance. Nephron1997; 75: 1-6.
• 3. Arieff AI . Dialysis disequilibrium syndrome: Current concepts on pathogenesis and prevention. Kidney International 1994; 45:629-635.
• 4. Tang, H.U, Wong, S.H., Chu, K.H., et al. Sodium ramping reduces hypotension and symptoms during haemodialysis. Hong Kong Medical Journal 2006;12 :10-22.
• 5. United States Renal Data System. USRDS 2005 Annual Data Report: Atlas of End-stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2005.
• 6. Jablonski A. Level of symptom relief and the need for palliative care in the hemodialysis population. Journal of Hospice and Palliative Nursing 2007;9(1):50-58.
• 7. Moss AH, Holley JL, Davison SN, et al. Core curriculum in nephrology. Palliative care.Am J Kidney Dis 2004;42(1):172-185.
• 8. World Health Organization. Cancer Pain Relief and Palliative Care. (Technical report series 804). Geneva: World Health Organization; 1990.
• 9. Kinzbrunner BM. Palliative care perspectives. In: Kuebler KK, Davis MP, Moore CD, eds. Palliative Practices: An Interdisciplinary Approach. St. Louis, MO: Mosby; 2005:3-28.
• 10. Poppel DM, Cohen LM, Germain MJ. The renal palliative care initiative. J Palliat Med 2003;6(2):321-326.
• 11. Dodd M, Lee K, Carrieri V. Symptom management model. Journal of Hospice and Palliative Nursing 2005; 7(21):23-36.
• 12. Parfrey PS, Vavasour H, Henry S, et al. Clinical features and severity of nonspecific symptoms in dialysis patients. Nephron 1988;50(2):121-129.
• 13. Curtin R, Bultman D, Thomas-Hawkins C. Hemodialysis patients' symptom experiences: Effects on physical and mental functioning. Nephrol Nurs J 2002;29(6):562-574.
• 14. Dodd MJ, Janson S, Carrieri-Kolhman V, et al. Advancing the science of symptom management. J Adv Nurs 2001;33:668-676.
• 15. The University of California, San Francisco School of Nursing Symptom Management Group. A model for symptom management. J Nurs Scholarsh 1994;26:272-276.
• 16. Foley KM, Gelband H. Improving Palliative Care for Cancer. Summary and Recommendations. Washington, DC: National Academy Press; 2003.
• 17. Movilli E, Camerini C, Viola BF, et al. Blood volume changes during three different profiles of dialysate sodium variation with similar intradialytic sodium balances in chronic hemodialyzed patients. American Journal of Kidney Disease 1997; 30: 58-63
• 18. Stiller S, Btmnie-Schom E, Grassmann A, Uhlenbusch-Korwer I, Mann H. A critical review of sodium profiling for hemodialysis. Seminars in Dialysis 2001: 14: 337-347.
• 19. Bossola M, TazzaL, Giungi S, Luciani G. Anorexia in hemodialysis patients: An update. Kidney International 2006; 70, 417–422.
• 20. Burrowes JD, Larive BL, Cockram DB et al. Effects of dietary intake, appetite, and eating habits on dialysis and non-dialysis treatment days in HD patients: cross sectional results from the HEMO study. J Renal Nutr 2003; 13: 191–198.
• 21. Kalantar-Zadeh K, Block G, McAllister CJ et al. Appetite and inflammation, nutrition, anemia, and clinical outcome in HD patients. Am J Clin Nutr 2004; 80: 299–307.
• 22. Suri RS, Nesrallah GE, Mainra R et al. Daily hemodialysis: a systematic review. Clin J Am Soc Nephrol 2006; 1: 33–42.
• 23. Ahsan M, Gupta M, Omar I, et al. Prevention of hemodialysisrelated muscle cramps by intradialyticuse of sequential compression devices: a report of four cases. Hemodial Int 2004; 8:283–286.
• 24. Khajedehi P, Morerlou M, Behzadi S, et al. A randomized, double- blind, placebo-controlled trial of supplementary vitamins E, C and their combination for treatment of haemodialysis cramps. Nephrol Dial Transplant 2001; 16:1448–1451.
• 25. Canzanello VJ, Burkart JM: Hemodialysis-associated muscle cramps. Semin Dial 1992; 5:299–304,
• 26. McGee SR: Muscle cramps. Arch Intern Med 1990; 150:511–518.
• 27. Rocco MV, Burkart JM: Prevalence of missed treatments and early sign-offs in hemodialysis patients. J Am Soc Nephrol 1993; 4:1178–1183..
• 28. Hernando P, Carmelo C, Lopez Garcia D, et al Musclecramps: a cause of elevated creatinine kinase levels in hemodialysispatients. Nephron 1990; 55:231–232.
• 29. Sidhom A, Odeh YK, Krumlovsky FA, et al. Low-dose prazosin in patients with muscle crampsduring hemodialysis. Clin Pharmacol Ther 56:445–451, 1994.
• 30. Ahmad S: L-carnitine in dialysis patients. Semin Dial 2001; 14:209–217.
• 31. Peer G, Blum M, Aviram A: Relief of hemodialysis-induced musclecramps by nifedipine. Dial Transplant 1989; 12:180–181.